SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-117760
Filing Date
2018-04-16
Accepted
2018-04-16 07:31:02
Documents
10
Effectiveness Date
2018-04-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A d572410ddefa14a.htm DEFA14A 36027
2 GRAPHIC g572410txs1g1.jpg GRAPHIC 898460
3 GRAPHIC g572410txs2g1.jpg GRAPHIC 1807274
4 GRAPHIC g572410txs3g1.jpg GRAPHIC 1302851
5 GRAPHIC g572410txs4g1.jpg GRAPHIC 1413942
6 GRAPHIC g572410txs5g1.jpg GRAPHIC 1480065
7 GRAPHIC g572410txs6g1.jpg GRAPHIC 686804
8 GRAPHIC g572410txs7g1.jpg GRAPHIC 1329609
9 GRAPHIC g572410txs8g1.jpg GRAPHIC 965622
10 GRAPHIC g572410txs9g1.jpg GRAPHIC 1466668
  Complete submission text file 0001193125-18-117760.txt   15670367
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36867 | Film No.: 18755570
SIC: 2834 Pharmaceutical Preparations